Business Wire

Mavenir and HCL Collaborate on Integration and Delivery of O-RAN Compliant Radios

14.10.2021 16:00:00 EEST | Business Wire | Press release

Share

Mavenir, the Network Software Provider building the future of networks with cloud-native software that runs on any cloud and transforms the way the world connects, today announced a strategic partnership with HCL Technologies (HCL), a leading global technology company with expertise in network systems testing. This partnership helps accelerate the market availability of O-RAN split 7.2 compliant Remote Radiohead Units (RRUs) while establishing a business model to meet the growing demand and evolving requirements for O-RAN RRUs.

Today’s RRU ecosystem has expanded to offer Communication Service Providers (CSPs) a significantly wider choice of 2G, 3G, 4G, 5G, massive MIMO (mMIMO), millimeter Wave (mmWave), small cell and indoor radios. In turn, the number of RRU partners that Mavenir works with continues to grow, with each partner releasing new and sophisticated radios, with new software, across different radio technologies, output power, antenna dimensions and spectrum to meet the evolving needs of O-RAN customers.

The collaboration brings together HCL’s platform for third-party RRU testing and Mavenir’s full Centralized Unit (CU) and Distributed Unit (DU) RAN software stacks. RRU vendors will, as a result, be given the ability to work directly with HCL to assess their O-RAN interfaces and integrate with Mavenir’s O-RAN compliant cloud-native CU/DU software.

By simplifying testing and validation across multiple O-RAN interoperability profiles, the collaboration will help vendors fast-track validation of frequency variants and the increasingly diverse RRU offerings being demanded by the O-RAN market.

This partnership will benefit both RRU vendors and CSPs by supporting the continued expansion of the radio ecosystem and helping to establish a self-sustaining RRU business model:

  • Vendors will be able to rapidly validate their O-RAN compliant RRUs as they develop portfolios of products targeted at different deployment scenarios.
  • CSPs will be able to more easily identify the available O-RAN compliant RRU options for specific use cases and locations.

“We are directly addressing requests from customers and partners to speed the integration of new RRU products. The growing scale of the O-RAN industry now demands such a model. And thanks to O-RAN and open interfaces, new players such as HCL can enter the market to effectively serve the market needs,” said Mavenir’s Puneet Sethi, SVP/GM RAN Business Unit. “As more O-RAN RRU products become available and RRU partners are enabled to respond rapidly to their customers, CSPs worldwide will be able to take advantage of the full range of their spectrum assets and benefit from the rapidly accelerating RRU ecosystem.”

“The Mavenir-HCL partnership helps accelerate the O-RAN market, bringing a new suite of product offerings to CSPs and enterprises alike. This sets the stage for a nascent ecosystem accelerating future innovation across key verticals on a global scale,” said HCL’s Rajiv Shesh, Corporate Vice President, Engineering and R&D Services. “HCL is bringing together many decades of network testing experience, 5G expertise, state of the art lab facilities and advanced automation tools to validate the interoperability between Mavenir and RRU partners. HCL provides the necessary visibility and reporting capability that enables operators and enterprises in deploying best-of-breed Mavenir O-RAN solutions.”

About Mavenir

Mavenir is building the future of networks and pioneering advanced technology, focusing on the vision of a single, software-based automated network that runs on any cloud. As the industry’s only end-to-end, cloud-native network software provider, Mavenir is focused on transforming the way the world connects, accelerating software network transformation for 250+ Communications Service Providers in over 120 countries, which serve more than 50% of the world’s subscribers. www.mavenir.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Maryvonne Tubb
Mavenir
PR@mavenir.com

Casey Bush
GlobalResultsPR (US)
mavenir@globalresultspr.com

Kevin Taylor
GlobalResultsPR (EMEA)
mavenir@globalresultspr.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 15:00:00 EEST | Press release

Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar

ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 15:00:00 EEST | Press release

ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful innovation to patients through technologies that advance precision, safety, and the overall treatment experience,” said Sheraz Daya, MD, Medical Director and Founder of Centre for Sight. “We are proud to be the first center globally

BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 15:00:00 EEST | Press release

BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures and HEPATOMUNE® tri-cultures. Additionally, Christian Smith, Scientist I, R&D at BioIVT will present a poster titled "Therapeutic Reversal of Established Steatosis Usin

IHS Towers Publishes 2025 Sustainability Report26.5.2026 13:34:00 EEST | Press release

IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, has today published its 2025 Sustainability Report. The report covers sustainability activities from January 1, 2025 to December 31, 2025 and demonstrates IHS Towers’ continued commitment to its stakeholders, including, but not limited to, its employees, customers, suppliers, local communities, regulators, governments and shareholders. IHS Towers’ vision is to help create a connected world, where mobile connectivity promotes continued economic growth and social development. The communications infrastructure it provides is vital to enabling that connectivity. In 2025, IHS Towers continued to advance its four-pillar sustainability strategy – focusing on ethics and governance, environment and climate change, education and economic growth, our people and communities – as detailed in this report. Sam Darwi

Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 202626.5.2026 13:30:00 EEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at 12:45pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational CO

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye